leuprolide and HIV-Infections

leuprolide has been researched along with HIV-Infections* in 2 studies

Reviews

1 review(s) available for leuprolide and HIV-Infections

ArticleYear
Approach to management of clinically localized prostate cancer in patients with human immunodeficiency virus.
    Urology, 2005, Volume: 65, Issue:1

    To evaluate the approach to management of localized prostate cancer (PCa) in patients with human immunodeficiency virus (HIV) in the highly active antiretroviral therapy era.. A retrospective analysis was performed on 10 HIV-positive patients who recently presented with elevated prostate-specific antigen levels and clinically localized PCa.. At the diagnosis of PCa, the average patient was 54.0 years old, had been HIV positive for 8.75 years, had a CD4 count of 417, a prostate-specific antigen level of 9.2 ng/mL, and a Gleason score of 6. Eight of the patients had risk factors for PCa--either African-American descent (n = 6) or a positive family history (n = 2). The treatment was laparoscopic radical prostatectomy in 1, potency-preserving androgen deprivation in 1, cryosurgery in 1, brachytherapy in 2, observation in 2, and external beam radiotherapy in 3.. Screening of all HIV-positive men should be initiated at age 40 if they have either a positive family history of prostate cancer or are of African-American descent. Asymptomatic HIV-positive patients should be offered all therapeutic PCa treatment options.

    Topics: Adenocarcinoma; Adult; Aged; Anilides; Antineoplastic Agents, Hormonal; Antiretroviral Therapy, Highly Active; Biomarkers, Tumor; Brachytherapy; Case Management; Combined Modality Therapy; Cryosurgery; Finasteride; Follow-Up Studies; HIV Infections; Humans; Leuprolide; Life Expectancy; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Proteins; Nitriles; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiotherapy, High-Energy; Retrospective Studies; Tosyl Compounds

2005

Other Studies

1 other study(ies) available for leuprolide and HIV-Infections

ArticleYear
Congenital HIV infection and precocious puberty.
    Journal of pediatric endocrinology & metabolism : JPEM, 2003, Volume: 16, Issue:5

    Reported endocrine problems related to human immunodeficiency virus (HIV) infection in children are primarily growth deceleration and delayed pubertal development. We report here an African-American male with congenital HIV infection who developed precocious puberty that was diagnosed at 4-9/12 years of age.

    Topics: Adolescent; Child Development; Child, Preschool; Fertility Agents, Female; HIV Infections; Humans; Leuprolide; Male; Puberty, Precocious; Testis

2003